{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:45:53Z","timestamp":1777985153168,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005683","name":"Kyoto University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005683","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.alit.2025.04.003","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T07:23:40Z","timestamp":1747639420000},"page":"605-615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Neutrophils predominate as IL1B-expressing cells in Schnitzler syndrome: Insights from the SCan study to evaluate the efficacy and safety of canakinumab in Japanese patients"],"prefix":"10.1016","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9610-4952","authenticated-orcid":false,"given":"Naotomo","family":"Kambe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1226-5183","authenticated-orcid":false,"given":"Norimitsu","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Ueki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Yonekura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Katsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9332-0369","authenticated-orcid":false,"given":"Satoshi","family":"Nakamizo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Tsujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuki","family":"Ohtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Yoshifuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyasu","family":"Jo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazushi","family":"Izawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayuko","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Takemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-ichiro","family":"Kagami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshie","family":"Kawahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Amino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumiko","family":"Ibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuo","family":"Kanazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.alit.2025.04.003_bib1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3390\/biom14060646","article-title":"Schnitzler syndrome: insights into its pathogenesis, clinical manifestations, and current management","volume":"14","author":"Braud","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.alit.2025.04.003_bib2","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/all.12129","article-title":"Schnitzler's syndrome: diagnosis, treatment, and follow-up","volume":"68","author":"Simon","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2025.04.003_bib3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.alit.2023.02.005","article-title":"Similarities and differences in autoinflammatory diseases with urticarial rash, cryopyrin-associated periodic syndrome and Schnitzler syndrome","volume":"72","author":"Matsuda","year":"2023","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2025.04.003_bib4","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1007\/s10067-020-05204-2","article-title":"A Chinese case series of Schnitzler syndrome and complete remission in one tocilizumab-treated patient","volume":"39","author":"Yan","year":"2020","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.alit.2025.04.003_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000143499","article-title":"Schnitzler's syndrome: monoclonal gammopathy associated with chronic urticaria","volume":"120","author":"Rizzi","year":"2008","journal-title":"Acta Haematol"},{"key":"10.1016\/j.alit.2025.04.003_bib6","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jaci.2009.10.066","article-title":"Genetic predisposition (NLRP3 V198M mutation) for IL-1-mediated inflammation in a patient with Schnitzler syndrome","volume":"125","author":"Loock","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2025.04.003_bib7","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jaci.2014.07.050","article-title":"Myeloid lineage-restricted somatic mosaicism of NLRP3 mutations in patients with variant Schnitzler syndrome","volume":"135","author":"de Koning","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2025.04.003_bib8","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1111\/all.15411","article-title":"Absence of NLRP3 somatic mutations and VEXAS-related UBA1 mutations in a large cohort of patients with Schnitzler syndrome","volume":"77","author":"Louvrier","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2025.04.003_bib9","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/art.41030","article-title":"Exploratory study of MYD88 L265P, rare NLRP3 variants, and clonal hematopoiesis prevalence in patients with Schnitzler syndrome","volume":"71","author":"Pathak","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.alit.2025.04.003_bib10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.alit.2022.11.004","article-title":"Summary of the current status of clinically diagnosed cases of Schnitzler syndrome in Japan","volume":"72","author":"Takimoto-Ito","year":"2023","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2025.04.003_bib11","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1002\/art.21101","article-title":"Successful treatment of refractory Schnitzler syndrome with anakinra: comment on the article by Hawkins et al","volume":"52","author":"Martinez-Taboada","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.alit.2025.04.003_bib12","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/ard.2005.045245","article-title":"Beneficial response to anakinra and thalidomide in Schnitzler's syndrome","volume":"65","author":"de Koning","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.alit.2025.04.003_bib13","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1398-9995.2012.02843.x","article-title":"Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome: an open-label study","volume":"67","author":"Krause","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2025.04.003_bib14","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.jaci.2019.12.909","article-title":"Long-term efficacy of canakinumab in the treatment of Schnitzler syndrome","volume":"145","author":"Krause","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2025.04.003_bib15","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jaci.2016.07.041","article-title":"Efficacy and safety of canakinumab in Schnitzler syndrome: a multicenter randomized placebo-controlled study","volume":"139","author":"Krause","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2025.04.003_bib16","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1136\/annrheumdis-2012-202192","article-title":"Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler's syndrome","volume":"72","author":"de Koning","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.alit.2025.04.003_bib17","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1016\/j.jaip.2021.01.024","article-title":"Tocilizumab treatment in patients with Schnitzler syndrome: an open-label study","volume":"9","author":"Bonnekoh","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2025.04.003_bib18","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.alit.2024.10.001","article-title":"Investigator-initiated, multi-center, single-arm, open-label study of the effectiveness of canakinumab in Japanese patients with Schnitzler syndrome","volume":"2","author":"Kambe","year":"2025","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2025.04.003_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13075-015-0696-0","article-title":"The role of interleukin-1 beta in the pathophysiology of Schnitzler's syndrome","volume":"17","author":"de Koning","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.alit.2025.04.003_bib20","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/bjd.15705","article-title":"Use of skin biomarker profiles to distinguish Schnitzler syndrome from chronic spontaneous urticaria: results of a pilot study","volume":"178","author":"Bonnekoh","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2025.04.003_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.576200","article-title":"Case report: extensive phosphorylation of interleukin-1 receptor-associated kinase 4 in a patient with Schnitzler syndrome","volume":"11","author":"Hodl","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.alit.2025.04.003_bib22","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/bjd.17334","article-title":"Association of CCL2 with systemic inflammation in Schnitzler syndrome","volume":"180","author":"Krause","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2025.04.003_bib23","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3389\/fphar.2017.00278","article-title":"Potential of IL-1, IL-18 and inflammasome inhibition for the treatment of inflammatory skin diseases","volume":"8","author":"Fenini","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.alit.2025.04.003_bib24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nri2079","article-title":"The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling","volume":"7","author":"O'Neill","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.alit.2025.04.003_bib25","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.alit.2025.04.003_bib26","first-page":"2011","article-title":"Retention rate of IL-1 inhibitors in Schnitzler's syndrome","volume":"40","author":"Crisafulli","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.alit.2025.04.003_bib27","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1084\/jem.20082481","article-title":"In vivo regulation of interleukin 1beta in patients with cryopyrin-associated periodic syndromes","volume":"206","author":"Lachmann","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.alit.2025.04.003_bib28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.immuni.2012.04.013","article-title":"Critical role for mast cells in interleukin-1beta-driven skin inflammation associated with an activating mutation in the nlrp3 protein","volume":"37","author":"Nakamura","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.alit.2025.04.003_bib29","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1084\/jem.20082179","article-title":"Mast cells mediate neutrophil recruitment and vascular leakage through the NLRP3 inflammasome in histamine-independent urticaria","volume":"206","author":"Nakamura","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.alit.2025.04.003_bib30","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/bjd.13857","article-title":"Mast-cell interleukin-1\u03b2, neutrophil interleukin-17 and epidermal antimicrobial proteins in the neutrophilic urticarial dermatosis in Schnitzler's syndrome","volume":"173","author":"de Koning","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2025.04.003_bib31","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201466","article-title":"Neutrophil-specific gain-of-function mutations in Nlrp3 promote development of cryopyrin-associated periodic syndrome","volume":"218","author":"Stackowicz","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.alit.2025.04.003_bib32","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3389\/fimmu.2019.00546","article-title":"Skin and systemic inflammation in Schnitzler's syndrome are associated with neutrophil extracellular trap formation","volume":"10","author":"Bonnekoh","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.alit.2025.04.003_bib33","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211083","article-title":"Neutrophil DREAM promotes neutrophil recruitment in vascular inflammation","volume":"219","author":"Li","year":"2022","journal-title":"J Exp Med"},{"key":"10.1016\/j.alit.2025.04.003_bib34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.immuni.2012.01.012","article-title":"Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation","volume":"36","author":"Vince","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.alit.2025.04.003_bib35","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3389\/fimmu.2020.00721","article-title":"The CD83 molecule - an important immune checkpoint","volume":"11","author":"Grosche","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.alit.2025.04.003_bib36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.smim.2016.04.003","article-title":"Neutrophil-derived chemokines on the road to immunity","volume":"28","author":"Tecchio","year":"2016","journal-title":"Semin Immunol"},{"key":"10.1016\/j.alit.2025.04.003_bib37","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaci.2024.10.035","article-title":"Bruton's tyrosine kinase (BTK) and matrix metalloproteinase-9 (MMP-9) regulate NLRP3 inflammasome-dependent cytokine and neutrophil extracellular trap responses in primary neutrophils","volume":"155","author":"Leal","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2025.04.003_bib38","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1111\/1346-8138.16124","article-title":"Refractory serum immunoglobulin M elevation during anti-interleukin (IL)-1- or IL-6-targeted treatment in four patients with Schnitzler syndrome","volume":"48","author":"Takimoto-Ito","year":"2021","journal-title":"J Dermatol"},{"key":"10.1016\/j.alit.2025.04.003_bib39","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1182\/blood.2023023105","article-title":"IL-1 in aging and pathologies of hematopoietic stem cells","volume":"144","author":"Caiado","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.alit.2025.04.003_bib40","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1182\/bloodadvances.2023011338","article-title":"IL-1beta promotes MPN disease initiation by favoring early clonal expansion of JAK2-mutant hematopoietic stem cells","volume":"8","author":"Rai","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.alit.2025.04.003_bib41","doi-asserted-by":"crossref","first-page":"7471","DOI":"10.1182\/bloodadvances.2023011578","article-title":"Effects of IL-1beta inhibition on anemia and clonal hematopoiesis in the randomized CANTOS trial","volume":"7","author":"Woo","year":"2023","journal-title":"Blood Adv"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893025000486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893025000486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T14:53:21Z","timestamp":1761836001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1323893025000486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1323893025000486"],"URL":"https:\/\/doi.org\/10.1016\/j.alit.2025.04.003","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutrophils predominate as IL1B-expressing cells in Schnitzler syndrome: Insights from the SCan study to evaluate the efficacy and safety of canakinumab in Japanese patients","name":"articletitle","label":"Article Title"},{"value":"Allergology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alit.2025.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese Society of Allergology. Published by Elsevier B.V\u00e9","name":"copyright","label":"Copyright"}]}}